Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Research presented today at SfN’s annual meeting has detailed advances in brain stimulation technologies revealing safer, more targeted means of studying brain function and treating neurological disorders.
Researchers have suggested that NF-ƙB-TNFα signaling is the principle origin of obsessive behavioral abnormalities in frontotemporal dementia.
In a new study, researchers have investigated neural circuits in rats to understand fearful memory retrieval, finding that place cell firing patterns are involved in avoidance behaviors.
In this interview, we speak to Elena Minakova, a Fellow in Neonatology at UCLA who is investigating a role for Melanotan-II in reducing social deficits in autism.
The Halting Antipsychotic use in Long Term care Project has highlighted a new method for successfully reducing the use of antipsychotics to control behavioral and psychological symptoms of dementia.
New research presented at FENS Forum of Neuroscience has highlighted the complex relationship between oleoylethanolamide and the brain’s histamine system.
A new model is proposed that the Basal Ganglia implement the level of transition control in an extended control hierarchy, helping to explain major neurological symptoms.